Antisense Oligonucleotides Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antisense Oligonucleotides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 RNA Antisense Oligonucleotides
        1.2.3 DNA Antisense Oligonucleotides
    1.3 Market by Application
        1.3.1 Global Antisense Oligonucleotides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antisense Oligonucleotides Market Perspective (2017-2028)
    2.2 Antisense Oligonucleotides Growth Trends by Region
        2.2.1 Antisense Oligonucleotides Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antisense Oligonucleotides Historic Market Size by Region (2017-2022)
        2.2.3 Antisense Oligonucleotides Forecasted Market Size by Region (2023-2028)
    2.3 Antisense Oligonucleotides Market Dynamics
        2.3.1 Antisense Oligonucleotides Industry Trends
        2.3.2 Antisense Oligonucleotides Market Drivers
        2.3.3 Antisense Oligonucleotides Market Challenges
        2.3.4 Antisense Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antisense Oligonucleotides Players by Revenue
        3.1.1 Global Top Antisense Oligonucleotides Players by Revenue (2017-2022)
        3.1.2 Global Antisense Oligonucleotides Revenue Market Share by Players (2017-2022)
    3.2 Global Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antisense Oligonucleotides Revenue
    3.4 Global Antisense Oligonucleotides Market Concentration Ratio
        3.4.1 Global Antisense Oligonucleotides Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides Revenue in 2021
    3.5 Antisense Oligonucleotides Key Players Head office and Area Served
    3.6 Key Players Antisense Oligonucleotides Product Solution and Service
    3.7 Date of Enter into Antisense Oligonucleotides Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotides Breakdown Data by Type
    4.1 Global Antisense Oligonucleotides Historic Market Size by Type (2017-2022)
    4.2 Global Antisense Oligonucleotides Forecasted Market Size by Type (2023-2028)
5 Antisense Oligonucleotides Breakdown Data by Application
    5.1 Global Antisense Oligonucleotides Historic Market Size by Application (2017-2022)
    5.2 Global Antisense Oligonucleotides Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antisense Oligonucleotides Market Size (2017-2028)
    6.2 North America Antisense Oligonucleotides Market Size by Type
        6.2.1 North America Antisense Oligonucleotides Market Size by Type (2017-2022)
        6.2.2 North America Antisense Oligonucleotides Market Size by Type (2023-2028)
        6.2.3 North America Antisense Oligonucleotides Market Share by Type (2017-2028)
    6.3 North America Antisense Oligonucleotides Market Size by Application
        6.3.1 North America Antisense Oligonucleotides Market Size by Application (2017-2022)
        6.3.2 North America Antisense Oligonucleotides Market Size by Application (2023-2028)
        6.3.3 North America Antisense Oligonucleotides Market Share by Application (2017-2028)
    6.4 North America Antisense Oligonucleotides Market Size by Country
        6.4.1 North America Antisense Oligonucleotides Market Size by Country (2017-2022)
        6.4.2 North America Antisense Oligonucleotides Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Antisense Oligonucleotides Market Size (2017-2028)
    7.2 Europe Antisense Oligonucleotides Market Size by Type
        7.2.1 Europe Antisense Oligonucleotides Market Size by Type (2017-2022)
        7.2.2 Europe Antisense Oligonucleotides Market Size by Type (2023-2028)
        7.2.3 Europe Antisense Oligonucleotides Market Share by Type (2017-2028)
    7.3 Europe Antisense Oligonucleotides Market Size by Application
        7.3.1 Europe Antisense Oligonucleotides Market Size by Application (2017-2022)
        7.3.2 Europe Antisense Oligonucleotides Market Size by Application (2023-2028)
        7.3.3 Europe Antisense Oligonucleotides Market Share by Application (2017-2028)
    7.4 Europe Antisense Oligonucleotides Market Size by Country
        7.4.1 Europe Antisense Oligonucleotides Market Size by Country (2017-2022)
        7.4.2 Europe Antisense Oligonucleotides Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antisense Oligonucleotides Market Size (2017-2028)
    8.2 Asia-Pacific Antisense Oligonucleotides Market Size by Type
        8.2.1 Asia-Pacific Antisense Oligonucleotides Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Antisense Oligonucleotides Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Antisense Oligonucleotides Market Share by Type (2017-2028)
    8.3 Asia-Pacific Antisense Oligonucleotides Market Size by Application
        8.3.1 Asia-Pacific Antisense Oligonucleotides Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Antisense Oligonucleotides Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Antisense Oligonucleotides Market Share by Application (2017-2028)
    8.4 Asia-Pacific Antisense Oligonucleotides Market Size by Region
        8.4.1 Asia-Pacific Antisense Oligonucleotides Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Antisense Oligonucleotides Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Antisense Oligonucleotides Market Size (2017-2028)
    9.2 Latin America Antisense Oligonucleotides Market Size by Type
        9.2.1 Latin America Antisense Oligonucleotides Market Size by Type (2017-2022)
        9.2.2 Latin America Antisense Oligonucleotides Market Size by Type (2023-2028)
        9.2.3 Latin America Antisense Oligonucleotides Market Share by Type (2017-2028)
    9.3 Latin America Antisense Oligonucleotides Market Size by Application
        9.3.1 Latin America Antisense Oligonucleotides Market Size by Application (2017-2022)
        9.3.2 Latin America Antisense Oligonucleotides Market Size by Application (2023-2028)
        9.3.3 Latin America Antisense Oligonucleotides Market Share by Application (2017-2028)
    9.4 Latin America Antisense Oligonucleotides Market Size by Country
        9.4.1 Latin America Antisense Oligonucleotides Market Size by Country (2017-2022)
        9.4.2 Latin America Antisense Oligonucleotides Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antisense Oligonucleotides Market Size (2017-2028)
    10.2 Middle East & Africa Antisense Oligonucleotides Market Size by Type
        10.2.1 Middle East & Africa Antisense Oligonucleotides Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Antisense Oligonucleotides Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Antisense Oligonucleotides Market Share by Type (2017-2028)
    10.3 Middle East & Africa Antisense Oligonucleotides Market Size by Application
        10.3.1 Middle East & Africa Antisense Oligonucleotides Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Antisense Oligonucleotides Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Antisense Oligonucleotides Market Share by Application (2017-2028)
    10.4 Middle East & Africa Antisense Oligonucleotides Market Size by Country
        10.4.1 Middle East & Africa Antisense Oligonucleotides Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Antisense Oligonucleotides Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Ionis Pharmaceuticals
        11.1.1 Ionis Pharmaceuticals Company Details
        11.1.2 Ionis Pharmaceuticals Business Overview
        11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Introduction
        11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.1.5 Ionis Pharmaceuticals Recent Developments
    11.2 Sarepta Therapeutics
        11.2.1 Sarepta Therapeutics Company Details
        11.2.2 Sarepta Therapeutics Business Overview
        11.2.3 Sarepta Therapeutics Antisense Oligonucleotides Introduction
        11.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.2.5 Sarepta Therapeutics Recent Developments
    11.3 Biogen
        11.3.1 Biogen Company Details
        11.3.2 Biogen Business Overview
        11.3.3 Biogen Antisense Oligonucleotides Introduction
        11.3.4 Biogen Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.3.5 Biogen Recent Developments
    11.4 Alnylam Pharmaceuticals
        11.4.1 Alnylam Pharmaceuticals Company Details
        11.4.2 Alnylam Pharmaceuticals Business Overview
        11.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Introduction
        11.4.4 Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.4.5 Alnylam Pharmaceuticals Recent Developments
    11.5 Antisense Therapeutics
        11.5.1 Antisense Therapeutics Company Details
        11.5.2 Antisense Therapeutics Business Overview
        11.5.3 Antisense Therapeutics Antisense Oligonucleotides Introduction
        11.5.4 Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.5.5 Antisense Therapeutics Recent Developments
    11.6 Isarna Therapeutics
        11.6.1 Isarna Therapeutics Company Details
        11.6.2 Isarna Therapeutics Business Overview
        11.6.3 Isarna Therapeutics Antisense Oligonucleotides Introduction
        11.6.4 Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.6.5 Isarna Therapeutics Recent Developments
    11.7 Arrowhead Pharmaceuticals
        11.7.1 Arrowhead Pharmaceuticals Company Details
        11.7.2 Arrowhead Pharmaceuticals Business Overview
        11.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Introduction
        11.7.4 Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.7.5 Arrowhead Pharmaceuticals Recent Developments
    11.8 Atlantic Pharmaceuticals
        11.8.1 Atlantic Pharmaceuticals Company Details
        11.8.2 Atlantic Pharmaceuticals Business Overview
        11.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Introduction
        11.8.4 Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.8.5 Atlantic Pharmaceuticals Recent Developments
    11.9 Enzon Pharmaceuticals
        11.9.1 Enzon Pharmaceuticals Company Details
        11.9.2 Enzon Pharmaceuticals Business Overview
        11.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Introduction
        11.9.4 Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.9.5 Enzon Pharmaceuticals Recent Developments
    11.10 Bio-Path Holdings
        11.10.1 Bio-Path Holdings Company Details
        11.10.2 Bio-Path Holdings Business Overview
        11.10.3 Bio-Path Holdings Antisense Oligonucleotides Introduction
        11.10.4 Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.10.5 Bio-Path Holdings Recent Developments
    11.11 GlaxoSmithKline
        11.11.1 GlaxoSmithKline Company Details
        11.11.2 GlaxoSmithKline Business Overview
        11.11.3 GlaxoSmithKline Antisense Oligonucleotides Introduction
        11.11.4 GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.11.5 GlaxoSmithKline Recent Developments
    11.12 Geron
        11.12.1 Geron Company Details
        11.12.2 Geron Business Overview
        11.12.3 Geron Antisense Oligonucleotides Introduction
        11.12.4 Geron Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.12.5 Geron Recent Developments
    11.13 ICO Therapeutics
        11.13.1 ICO Therapeutics Company Details
        11.13.2 ICO Therapeutics Business Overview
        11.13.3 ICO Therapeutics Antisense Oligonucleotides Introduction
        11.13.4 ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.13.5 ICO Therapeutics Recent Developments
    11.14 Marina Biotech
        11.14.1 Marina Biotech Company Details
        11.14.2 Marina Biotech Business Overview
        11.14.3 Marina Biotech Antisense Oligonucleotides Introduction
        11.14.4 Marina Biotech Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.14.5 Marina Biotech Recent Developments
    11.15 RXi Pharmaceuticals
        11.15.1 RXi Pharmaceuticals Company Details
        11.15.2 RXi Pharmaceuticals Business Overview
        11.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Introduction
        11.15.4 RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022)
        11.15.5 RXi Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Antisense Oligonucleotides Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of RNA Antisense Oligonucleotides
    Table 3. Key Players of DNA Antisense Oligonucleotides
    Table 4. Global Antisense Oligonucleotides Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Antisense Oligonucleotides Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Antisense Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Antisense Oligonucleotides Market Share by Region (2017-2022)
    Table 8. Global Antisense Oligonucleotides Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Antisense Oligonucleotides Market Share by Region (2023-2028)
    Table 10. Antisense Oligonucleotides Market Trends
    Table 11. Antisense Oligonucleotides Market Drivers
    Table 12. Antisense Oligonucleotides Market Challenges
    Table 13. Antisense Oligonucleotides Market Restraints
    Table 14. Global Antisense Oligonucleotides Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Antisense Oligonucleotides Revenue Share by Players (2017-2022)
    Table 16. Global Top Antisense Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides as of 2021)
    Table 17. Ranking of Global Top Antisense Oligonucleotides Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotides Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Antisense Oligonucleotides Product Solution and Service
    Table 21. Date of Enter into Antisense Oligonucleotides Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Antisense Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Antisense Oligonucleotides Revenue Market Share by Type (2017-2022)
    Table 25. Global Antisense Oligonucleotides Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Antisense Oligonucleotides Revenue Market Share by Type (2023-2028)
    Table 27. Global Antisense Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Antisense Oligonucleotides Revenue Share by Application (2017-2022)
    Table 29. Global Antisense Oligonucleotides Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Antisense Oligonucleotides Revenue Share by Application (2023-2028)
    Table 31. North America Antisense Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Antisense Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Antisense Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Antisense Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Antisense Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Antisense Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Antisense Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Antisense Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Antisense Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Antisense Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Antisense Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Antisense Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Antisense Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Antisense Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Antisense Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Antisense Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Antisense Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Antisense Oligonucleotides Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Antisense Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Antisense Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Antisense Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Antisense Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Antisense Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Antisense Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Antisense Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Antisense Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Antisense Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Antisense Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Antisense Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Antisense Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Ionis Pharmaceuticals Company Details
    Table 62. Ionis Pharmaceuticals Business Overview
    Table 63. Ionis Pharmaceuticals Antisense Oligonucleotides Product
    Table 64. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 65. Ionis Pharmaceuticals Recent Developments
    Table 66. Sarepta Therapeutics Company Details
    Table 67. Sarepta Therapeutics Business Overview
    Table 68. Sarepta Therapeutics Antisense Oligonucleotides Product
    Table 69. Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 70. Sarepta Therapeutics Recent Developments
    Table 71. Biogen Company Details
    Table 72. Biogen Business Overview
    Table 73. Biogen Antisense Oligonucleotides Product
    Table 74. Biogen Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 75. Biogen Recent Developments
    Table 76. Alnylam Pharmaceuticals Company Details
    Table 77. Alnylam Pharmaceuticals Business Overview
    Table 78. Alnylam Pharmaceuticals Antisense Oligonucleotides Product
    Table 79. Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 80. Alnylam Pharmaceuticals Recent Developments
    Table 81. Antisense Therapeutics Company Details
    Table 82. Antisense Therapeutics Business Overview
    Table 83. Antisense Therapeutics Antisense Oligonucleotides Product
    Table 84. Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 85. Antisense Therapeutics Recent Developments
    Table 86. Isarna Therapeutics Company Details
    Table 87. Isarna Therapeutics Business Overview
    Table 88. Isarna Therapeutics Antisense Oligonucleotides Product
    Table 89. Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 90. Isarna Therapeutics Recent Developments
    Table 91. Arrowhead Pharmaceuticals Company Details
    Table 92. Arrowhead Pharmaceuticals Business Overview
    Table 93. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product
    Table 94. Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 95. Arrowhead Pharmaceuticals Recent Developments
    Table 96. Atlantic Pharmaceuticals Company Details
    Table 97. Atlantic Pharmaceuticals Business Overview
    Table 98. Atlantic Pharmaceuticals Antisense Oligonucleotides Product
    Table 99. Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 100. Atlantic Pharmaceuticals Recent Developments
    Table 101. Enzon Pharmaceuticals Company Details
    Table 102. Enzon Pharmaceuticals Business Overview
    Table 103. Enzon Pharmaceuticals Antisense Oligonucleotides Product
    Table 104. Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 105. Enzon Pharmaceuticals Recent Developments
    Table 106. Bio-Path Holdings Company Details
    Table 107. Bio-Path Holdings Business Overview
    Table 108. Bio-Path Holdings Antisense Oligonucleotides Product
    Table 109. Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 110. Bio-Path Holdings Recent Developments
    Table 111. GlaxoSmithKline Company Details
    Table 112. GlaxoSmithKline Business Overview
    Table 113. GlaxoSmithKline Antisense Oligonucleotides Product
    Table 114. GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 115. GlaxoSmithKline Recent Developments
    Table 116. Geron Company Details
    Table 117. Geron Business Overview
    Table 118. Geron Antisense Oligonucleotides Product
    Table 119. Geron Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 120. Geron Recent Developments
    Table 121. ICO Therapeutics Company Details
    Table 122. ICO Therapeutics Business Overview
    Table 123. ICO Therapeutics Antisense Oligonucleotides Product
    Table 124. ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 125. ICO Therapeutics Recent Developments
    Table 126. Marina Biotech Company Details
    Table 127. Marina Biotech Business Overview
    Table 128. Marina Biotech Antisense Oligonucleotides Product
    Table 129. Marina Biotech Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 130. Marina Biotech Recent Developments
    Table 131. RXi Pharmaceuticals Company Details
    Table 132. RXi Pharmaceuticals Business Overview
    Table 133. RXi Pharmaceuticals Antisense Oligonucleotides Product
    Table 134. RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 135. RXi Pharmaceuticals Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antisense Oligonucleotides Market Share by Type: 2021 VS 2028
    Figure 2. RNA Antisense Oligonucleotides Features
    Figure 3. DNA Antisense Oligonucleotides Features
    Figure 4. Global Antisense Oligonucleotides Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Antisense Oligonucleotides Report Years Considered
    Figure 9. Global Antisense Oligonucleotides Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Antisense Oligonucleotides Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Antisense Oligonucleotides Market Share by Region: 2021 VS 2028
    Figure 12. Global Antisense Oligonucleotides Market Share by Players in 2021
    Figure 13. Global Top Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Antisense Oligonucleotides Revenue in 2021
    Figure 15. North America Antisense Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Antisense Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 17. North America Antisense Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 18. North America Antisense Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 19. United States Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Antisense Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Antisense Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Antisense Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Antisense Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 25. Germany Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Antisense Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Antisense Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Antisense Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Antisense Oligonucleotides Market Size Share by Region (2017-2028)
    Figure 35. China Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Antisense Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Antisense Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Antisense Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Antisense Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 45. Mexico Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Antisense Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Antisense Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Antisense Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Antisense Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 51. Turkey Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Antisense Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 55. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 56. Biogen Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 57. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 58. Antisense Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 59. Isarna Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 60. Arrowhead Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 61. Atlantic Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 62. Enzon Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 63. Bio-Path Holdings Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 64. GlaxoSmithKline Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 65. Geron Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 66. ICO Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 67. Marina Biotech Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 68. RXi Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed